These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29976503)

  • 21. [Concurrent chemoradiotherapy followed by consolidation chemotherapy and sequential chemoradiotherapy for stage III non-small cell lung cancer: comparison in 93 patients].
    Sun WZ; Song LP; Zhang YB; Ai T; Lu JL; Ren J; Gao Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):362-7. PubMed ID: 22445984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I study of concurrent real-time tumor-tracking thoracic radiation therapy with paclitaxel and carboplatin in locally advanced non-small cell lung cancer.
    Sakakibara-Konishi J; Oizumi S; Kinoshita I; Shinagawa N; Kikuchi J; Kato M; Inoue T; Katoh N; Onimaru R; Shirato H; Dosaka-Akita H; Nishimura M
    Lung Cancer; 2011 Nov; 74(2):248-52. PubMed ID: 21397973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bronchodilator response of advanced lung function parameters depending on COPD severity.
    Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of neoadjuvant chemoradiation on preoperative pulmonary physiology, postoperative respiratory complications and quality of life in patients with oesophageal cancer.
    Elliott JA; O'Byrne L; Foley G; Murphy CF; Doyle SL; King S; Guinan EM; Ravi N; Reynolds JV
    Br J Surg; 2019 Sep; 106(10):1341-1351. PubMed ID: 31282584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.
    Choy H; Akerley W; Safran H; Graziano S; Chung C; Williams T; Cole B; Kennedy T
    J Clin Oncol; 1998 Oct; 16(10):3316-22. PubMed ID: 9779707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?
    Leo F; Solli P; Spaggiari L; Veronesi G; de Braud F; Leon ME; Pastorino U
    Ann Thorac Surg; 2004 Jan; 77(1):260-5; discussion 265. PubMed ID: 14726074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary rehabilitation in non-small cell lung cancer patients after completion of treatment.
    Glattki GP; Manika K; Sichletidis L; Alexe G; Brenke R; Spyratos D
    Am J Clin Oncol; 2012 Apr; 35(2):120-5. PubMed ID: 21378541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity.
    Wang J; Cao J; Yuan S; Ji W; Arenberg D; Dai J; Stanton P; Tatro D; Ten Haken RK; Wang L; Kong FM
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):798-804. PubMed ID: 22836048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung.
    Suntharalingam M; Paulus R; Edelman MJ; Krasna M; Burrows W; Gore E; Wilson LD; Choy H
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):456-63. PubMed ID: 22543206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative evaluation of respiratory impedance using the forced oscillation technique: a prospective observational study.
    Nakano S; Nakahira J; Sawai T; Kuzukawa Y; Ishio J; Minami T
    BMC Anesthesiol; 2016 Jul; 16(1):32. PubMed ID: 27389091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
    Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH
    Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary function changes in lung-cancer patients treated with radiation with or without carboplatin.
    Groen HJ; van der Mark TW; van der Leest AH; de Vries EG; Mulder NH
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2044-8. PubMed ID: 8520774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in Pulmonary Function Following Image-Guided Stereotactic Lung Radiotherapy: Neither Lower Baseline Nor Post-SBRT Pulmonary Function Are Associated with Worse Overall Survival.
    Stone B; Mangona VS; Johnson MD; Ye H; Grills IS
    J Thorac Oncol; 2015 Dec; 10(12):1762-9. PubMed ID: 26334751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of forced oscillation technique to assess lung function in geriatric COPD population.
    Tse HN; Tseng CZ; Wong KY; Yee KS; Ng LY
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1105-18. PubMed ID: 27307726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
    Friedel G; Budach W; Dippon J; Spengler W; Eschmann SM; Pfannenberg C; Al-Kamash F; Walles T; Aebert H; Kyriss T; Veit S; Kimmich M; Bamberg M; Kohlhaeufl M; Steger V; Hehr T
    J Clin Oncol; 2010 Feb; 28(6):942-8. PubMed ID: 20100967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer.
    Kaira K; Tomizawa Y; Imai H; Sakurai R; Matsuura M; Yoshii A; Ochiai M; Kotake M; Ebara T; Saitoh JI; Sunaga N; Minato K; Saito R; Hisada T
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):165-171. PubMed ID: 27995307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study.
    Ferrero C; Badellino S; Filippi AR; Focaraccio L; Giaj Levra M; Levis M; Moretto F; Torchio R; Ricardi U; Novello S
    Lung Cancer; 2015 Sep; 89(3):350-6. PubMed ID: 26164208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer.
    Dandekar VK; Young J; Kiel K; Bonomi P; Fidler MJ; Batus M; Sher DJ
    Am J Clin Oncol; 2015 Dec; 38(6):605-9. PubMed ID: 24781341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction chemotherapy with cetuximab, vinorelbine-cisplatin followed by thoracic radiotherapy and concurrent cetuximab, vinorelbine-cisplatin in patients with unresectable stage III non-small cell lung cancer.
    Liu D; Zheng X; Chen J; Liu G; Xu Y; Shen Y; Xie L; Zhao W; Jiang G; Fan M
    Lung Cancer; 2015 Sep; 89(3):249-54. PubMed ID: 26118463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer.
    Choy H; Akerley W; Safran H; Graziano S; Chung C
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):117-9. PubMed ID: 9007137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.